Reed Garza, MD
Dermatology · Salem, UTNPI 1669715819
Payments from drug & device makers
Across 81 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$410
- Johnson & Johnson$195
- Pfizer$186
- Sanofi-aventis U.S. LLC$134
- Lilly USA, LLC$124
- Sanofi$104
- plus $573 from 14 others
What the payments were for
- Food & beverage$1,43183%
- Education$29417%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $410 |
| Johnson & Johnson | 2 | $195 |
| Pfizer | 12 | $186 |
| Sanofi-aventis U.S. LLC | 3 | $134 |
| Lilly USA, LLC | 8 | $124 |
| Sanofi | 5 | $104 |
| Novartis | 4 | $88 |
| VYNE Pharmaceuticals Inc. | 1 | $81 |
| Prugen, Inc. Pharmaceuticals | 3 | $79 |
| Amgen | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| LEO Pharma Inc. | 2 | $48 |
| Galderma Laboratories, L.p. | 2 | $30 |
| Boston Scientific | 1 | $24 |
| UCB, Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,725 in reported general payments places this provider in the 55th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 33 | $1,477 |
| Ketoconazole | 84 | $1,437 |
| Clobetasol Propionate | 34 | $1,349 |
| Triamcinolone Acetonide | 59 | $663 |
| Metronidazole | 15 | $615 |
| Betamethasone Dipropionate | 17 | $585 |
| Mupirocin | 53 | $552 |
| Fluocinolone Acetonide | 17 | $500 |
| Minoxidil | 18 | $289 |
| Doxycycline Hyclate | 18 | $271 |
| Hydrocortisone | 16 | $256 |
| Hydroxyzine Hcl | 11 | $227 |
| Doxycycline Monohydrate | 11 | $216 |
| Cephalexin | 23 | $101 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Salem
- Jamie RhoadsMurray$2.5M
- Doug Lass ForshaWest Jordan$2.2M
- Michael PetersonSpanish Fork$1.6M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Jason HadleyBountiful$477K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
- Douglas WosethSalt Lake$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.